Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Grow up.
"...Bashers are paid to drive stock price down with their bashes, and they absolutely NEVER back up any bash. They are paid by groups that are trying to manipulate price to their advantage. And, everyone that responds to a bash gets the basher another payment....."
Bought PIP some time ago for the one-time divy. Got it, then sold later when I thought it was about to tank. Then, like an idiot, I bought it back before the merger effective date thinking there would be a chance to make money off the new stock price. Should have put that money somewhere else. Like adding to HUN, BPT, PER, WILL, ETE, ON or other stocks I own. Live and learn.
Flippen Scalpers.
Effectively PIP was at $7 and now it's at $6. How's that a good thing?
Any news pip merger. Or any news on them.
Good morning and good luck to all. Hope you have a PIPin Rippin day!$$$
Trump hopefully will not allow any of our troops to be deployed without the best biological and chemical vaccines and protection.
I'll believe it when I see it!
Some say yes, some say no. Unclear what the final outcome will be. Investing? Hold long 1,2 yrs. Trading? More risk but sometimes better.
If that happens. Will stock go up alot. If that's the case they might do that before may 4.
Those anyone know if there is going to be a reverse split?
May 4th Unsure.
When is the merger meeting. And why did they changed it.
Actually, that is the payment to Alt in an all-stock purchase. It will be followed by a 1 for 10 reverse split. So, there will be 1/10 as many shares in the OS but each share will be worth 10X more. There is a mandatory stock price they have to reach to remain on the NYSE through this merger.
The new company will be ALT and PIP will be gone. Your takeaway is that you will own 1/10 as many shares as now, but they will be worth more and will become ALT shares.
Ok almost another 10 million shares issued again. Gheeshhhh
Like the way it's headed
Anyone know about the new S3 that authorizes more shares worth up to $100,000,000?
PIP S3
Usually, an A/S is defined by total share count, but this just says an indeterminate number of shares with that value. It is called a 'shelf' offering. Definition: Shelf Offering Definition
Is this just part of the machinations to accomplish the merger? I know there is a reverse split planned, but this is the opposite, and happens afterwards.
Not quite sure what this one means, but would like to know. I sold all my PIP a while back, but might buy back in if it looks attractive.
I hope so, and the 4th is not even here yet. Go pip
Looking good here in pre-market. Might be an interesting day.
MACK is next biotech stock that is set to declare a massive dividend like PIP did. Meeting to approve dividend is Thursday.
Hi clay I see your still shorting the fak out of this still my friend.
Supposed to be the 4th of next month, but they need to get some other good news out tomorrow or hell I might bail myself, granted I'm only down 348 bucks but still I could have spent that on something more worth while. Gltu.
Pip won a 216 million lawsuit and it is dropping this is unbelievable. What day is the merger meeting.
It is I forgot. I just can't wait for the merger it's going to make pip great again..
Meeting not until the 4th you are correct
I thought the meeting wasn't until the 4th of next month
Big day on Monday. Meeting on merger.. it's got to go thru.. it be great for pip..
I ment to say mustang merger owned by glad that trades in the $60 that will end up control of pip
Isn't pip owned by gilead sciences that trades in the $60s
* * $PIP Video Chart 03-15-17 * *
Link to Video - click here to watch the technical chart video
I expect PIP to move up, looking solid, be aware of shorts trying to spook you.
Imho
Do your DD
What's up with the pop this morning waiting on this thing can really run
Wow! Lot of movement. I am happy I held and bought more.
Pip @$1.02 P/M :)
Pips gonna pop tomorrow. Nice a/h spike.
Vet interesting report, I like. I think this is a keeper
Wonder what the combined market cap will be after merger
I have been here since $1.20 and I bought more when it went down to cost-average. I think this will go up eventually.
Followers
|
40
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1153
|
Created
|
08/29/07
|
Type
|
Free
|
Moderators |
http://www.pharmathene.com/
http://finance.yahoo.com/q/h?s=PIP
PharmAthene was formed to address the urgent biosecurity needs of this Nation and its Allies. Since the terrorist attacks in 2001 and the subsequent deliberate anthrax exposure to the U.S. population, the vulnerability of this Nation to a wide array of threats has come into sharp focus. Additionally, the Nation has recognized how woefully unprepared it is for future attacks. The U.S. Government has responded by allocating a significant amount of funding to develop technologies and products to address threats through development of the Department of Homeland Security and unprecedented funding for the biodefense market through the recently enacted Project BioShield Law. As a Company founded on the principle of developing a comprehensive array of countermeasures to biological and chemical terrorism, PharmAthene has demonstrated its ability to achieve its mission of being the leading developer and provider of countermeasures to potential bioweapons and is well positioned to be meet the urgent needs of the U.S. Government under the Project BioShield legislation.
PharmAthene is engaged in the discovery and development of new human therapeutics and prophylactics for the treatment and prevention of morbidity and mortality from exposure to chemical and biological weapons. PharmAthene's mission is to seize leadership in this emerging area by developing a portfolio of products urgently needed by the U.S. Government and its Allies. PharmAthene has two products under development that are intended to provide protection from anthrax and chemical threats. Beyond its initial focus in biodefense, PharmAthene intends to identify and develop dual-use technologies which have applications and indications in broader commercial markets.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |